Daptomycin for methicillin-resistant and methicillin-sensitive staphylococcus aureus infection a review of clinical effectiveness, cost-effectiveness and guidelines
The aim of this review is to summarize evidence on the comparative clinical and cost effectiveness of daptomycin to other antibiotics for the treatment of bacteremia and other infections caused by methicillin susceptible staphylococcus aureus (MSSA) or methicillin resistant staphylococcus aureus (MR...
Corporate Authors: | , |
---|---|
Format: | eBook |
Language: | English |
Published: |
Ottawa (ON)
CADTH Rapid Response Service
2016, 2016
|
Series: | Rapid response report: summary with critical appraisal
|
Subjects: | |
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | The aim of this review is to summarize evidence on the comparative clinical and cost effectiveness of daptomycin to other antibiotics for the treatment of bacteremia and other infections caused by methicillin susceptible staphylococcus aureus (MSSA) or methicillin resistant staphylococcus aureus (MRSA), and to summarize evidence-based guidelines regarding the use of daptomycin for MRSA and MSSA bacteremia or infection |
---|---|
Item Description: | "21 January 2016." |
Physical Description: | 1 PDF file (40 pages) illustration |